Research programme: DAC:GLP-2 - ConjuChem

Drug Profile

Research programme: DAC:GLP-2 - ConjuChem

Alternative Names: DAC:Glucagon-Like Peptide-2

Latest Information Update: 28 Aug 2009

Price : $50

At a glance

  • Originator ConjuChem Biotechnologies
  • Class Glucagon-like peptides
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.


Highest Development Phases

  • Discontinued Gastrointestinal disorders

Most Recent Events

  • 28 Aug 2009 Discontinued - Preclinical for Gastrointestinal disorders in Canada (unspecified route)
  • 19 Jul 2002 Preclinical trials in Gastrointestinal disorders in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top